A detailed history of Ubs Group Ag transactions in Viatris Inc stock. As of the latest transaction made, Ubs Group Ag holds 2,423,344 shares of VTRS stock, worth $30 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,423,344
Previous 2,211,822 9.56%
Holding current value
$30 Million
Previous $23.5 Million 19.67%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.32 - $12.13 $2.18 Million - $2.57 Million
211,522 Added 9.56%
2,423,344 $28.1 Million
Q2 2024

Aug 13, 2024

BUY
$10.05 - $12.02 $3.15 Million - $3.77 Million
313,557 Added 16.52%
2,211,822 $23.5 Million
Q1 2024

May 13, 2024

SELL
$11.27 - $13.53 $8.52 Million - $10.2 Million
-755,740 Reduced 28.48%
1,898,265 $22.7 Million
Q4 2023

Feb 09, 2024

SELL
$8.77 - $10.85 $9.71 Million - $12 Million
-1,107,127 Reduced 29.44%
2,654,005 $28.7 Million
Q3 2023

Nov 09, 2023

BUY
$9.59 - $11.35 $7.26 Million - $8.59 Million
756,875 Added 25.19%
3,761,132 $37.1 Million
Q2 2023

Aug 11, 2023

SELL
$9.02 - $10.29 $2.3 Million - $2.62 Million
-254,840 Reduced 7.82%
3,004,257 $30 Million
Q1 2023

May 12, 2023

BUY
$9.2 - $12.26 $7.4 Million - $9.86 Million
804,054 Added 32.75%
3,259,097 $31.4 Million
Q4 2022

Feb 08, 2023

SELL
$8.72 - $11.56 $6.37 Million - $8.45 Million
-730,641 Reduced 22.94%
2,455,043 $27.3 Million
Q3 2022

Nov 10, 2022

BUY
$8.48 - $11.13 $12.3 Million - $16.1 Million
1,450,288 Added 83.57%
3,185,684 $27.1 Million
Q2 2022

Aug 10, 2022

BUY
$9.95 - $12.27 $2.59 Million - $3.2 Million
260,675 Added 17.68%
1,735,396 $18.2 Million
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $6.98 Million - $11 Million
-711,861 Reduced 32.56%
1,474,721 $16 Million
Q4 2021

Feb 14, 2022

BUY
$12.09 - $14.68 $2.21 Million - $2.68 Million
182,750 Added 9.12%
2,186,582 $29.6 Million
Q3 2021

Nov 15, 2021

SELL
$13.25 - $15.13 $10.9 Million - $12.4 Million
-819,659 Reduced 29.03%
2,003,832 $27.2 Million
Q2 2021

Aug 13, 2021

SELL
$12.97 - $16.15 $4.95 Million - $6.16 Million
-381,297 Reduced 11.9%
2,823,491 $40.3 Million
Q1 2021

May 12, 2021

BUY
$13.59 - $18.54 $4.28 Million - $5.84 Million
315,061 Added 10.9%
3,204,788 $44.8 Million
Q4 2020

Feb 11, 2021

BUY
$14.3 - $18.74 $41.3 Million - $54.2 Million
2,889,727 New
2,889,727 $54.2 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.